AI-assisted diagnosis accuracy study for pathologists
Part of Cancer clinical trials.
This study tests whether an AI tool helps pathologists make more accurate diagnoses when looking at tissue samples. It may lead to better and faster diagnoses for patients in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a tissue sample that has been stained and prepared on a slide.
- The final diagnosis of your sample must be confirmed by molecular testing and expert review.
- Your sample must be of good quality and readable.
- Your sample must not have been used to train the AI tool.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an AI system to look at your tumor sample and test results to help match you with cancer clinical trials that might be a good fit. It aims to make it easier for doctors to find the most relevant trials for you based on your cancer's specific traits.
This study tests a new AI system called COSMO against pathologists to see which is better at diagnosing cancer from digital slides. If you are an experienced pathologist, you will review slides independently, and your results will be compared with the AI's.
This study is testing whether artificial intelligence (AI) can help doctors diagnose diseases from tissue samples more accurately. If you are a pathologist, you'll help compare AI-assisted diagnosis with traditional methods. If you are a patient, your stored tissue samples may be used to test the AI system.
This trial tests whether an AI tool helps pathologists read your tissue samples more accurately. It's a study for people who have had a stomach biopsy or gastric cancer surgery, where digital images of the tissue are available.
This trial uses artificial intelligence to analyze your pathology slides, radiology images, and medical records together. It aims to see how well AI can help with diagnosis or treatment planning, and you may qualify if your medical data is available and of good quality.
This trial uses artificial intelligence (AI) to help doctors more accurately identify early-stage breast cancer from test results. It could lead to faster and more precise diagnosis, which may help you get the right treatment sooner.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.